−455G/A Polymorphism of the β-Fibrinogen Gene is Associated With the Progression of Coronary Atherosclerosis in Symptomatic Men
Moniek P.M. de Maat, Cornelis Kluft(Leiden University Medical Center), Hans Jansen(Leiden University), J. Wouter Jukema(Leiden University Medical Center), John J.P. Kastelein(QRx Pharma (United States)), Bjørn Groenemeier(Leiden University Medical Center), Aeilko H. Zwinderman(Amsterdam Neuroscience), Albert V.G. Bruschke(Leiden University Medical Center)
Cited by 153
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k